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CONSUMER ISSUES REGARDING 
BOVINE 
SOMATOTROPIN (BST) 
Deanne Morse 
Extension Dairy Specialist 
One of the most nutritious foods is milk. Milk pro-
vides proteins, carbohydrates, fats, vitamins and 
minerals. Milk has been advertised as a wholesome 
product, and dairy producers work very hard to have 
their cows produce this healthy product. Why, then, 
is there sudden concern about milk being tainted 
with hormones? 
Industry members and researchers have devel-
oped and tested numerous feed enhancers. The pur-
pose behind enhancers is economics. If a producer 
can deliver the same quantity of milk from fewer 
cows, efficiency of production is most probably im-
proved. 
One of the most recent technologies to improve 
efficiency of milk production is a protein hormone, 
bovine somatotropin (BST). BST can be a production 
enhancer. 
Somatotropin is produced commercially via bio-
technology. The gene responsible for production of 
BST in dairy cows was isolated, and the genetiC 
material was transferred into bacterial cells. Private 
companies have utilized standard fermentation tech-
niques to mass produce BST in bacteria. The soma-
totropin is harvested and prepared for use in animal 
injections. 
Activity 
Somatotropins are species specific. Bovine soma-
totropin is active only in cattle, for example. For BST 
to be active in cattle, it must be injected. Oral doses 
of BST do not alter animal production. If given orally 
the protein is digested as any dietary protein is de-
graded. 
Milk from non-supplemented cows can contain 
trace amounts of BST. When the milk is consumed 
the BST is digested just as proteins are digested. 
Milk composition 
When cows are injected with BST they generally 
increase feed intake and milk production. The con-
tent of the milk is not altered. Milk fat, protein and 
solids-non-fat remain constant (Table 1). 
Table 1. Composition of milk from non·supplemented and 
BST supplemented cows. 
Component 
Protein % 
Fat % 
Total solids % 
BST supplement (mg/day) 
o 12.5 25 50 
3.00 
3.65 
12.31 
3.04 
4.00 
12.99 
3.03 
3.65 
12.55 
2.98 
4.00 
12.78 
Source: Bovine Somatotropin (BST) pamphlet produced by Animal Health 
Institute. 
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The protein content of milk ranges from 2.7 to 4.8 
percent. The predominant protein component in milk 
is casein. All other proteins in milk comprise non-
casein proteins desigQate9 as whey. Somatotropin 
in milk is located in the whey component. Casein 
represents 76 to 86 percent of milk protein. Lactal· 
bumin and lactoglobulin represent most of the whey 
component. Less than 2 percent of milk protein rep· 
resents other serum proteins. 
Trace amounts of SST have been detected in 
cows' milk. Concentration of SST in milk from dairy 
bulk tanks was determined by analyzing samples 
from more than 120 farms in Missouri and Illinois for 
SST. SST was detected in 12 of the samples. When 
detected, the concentration of SST in milk ranged 
from .33 to .77 ng/ml. The test used could not detect 
levels lower than .3 ng/ml. 
Milk samples from 40 individual cows were analyz-
ed for SST. Half of the cows received no SST sup-
plementation (control cows). The remaining 20 cows 
received the 14-day dose of prolonged release SST, 
which was implanted every two weeks for 14 weeks. 
Levels of SST in milk did not differ (Table 2). No dif· 
ferences in amount of SST in milk have been detec-
ted from cows supplemented with SST. 
Table 2. Detection of BST in milk. 
BST 
Control supplemented 
Weeks sampled 
Weeks BST < .3ng/ml 
Range when detected 
(ng/ml) 
14 
11 
.30 to .60 
14 
9 
.33 to .51 
Source: Torkelson and coworkers. J. Dairy Science 70:(1) 146. 
Makers of SST have performed hundreds of tests, 
and the Food and Drug Administration (FDA) approv-
ed SST for use in dairy cattle under experimental cir· 
cumstances. Sefore the FDA approves SST for use 
in commercial operations, long term studies must be 
completed. The purpose of the long term (one to two-
year) studies is to document cows' responsiveness 
to SST. Human health concerns have already been 
addressed. The FDA acknowledges that milk and 
meat from SST supplemented cows are safe for 
human consumption. These facts will not change as 
long term studies are completed. 
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